画像誘導ナビゲーション市場 – 2030年までの世界予測

Image-Guided Navigation Market - Global Forecast to 2030

画像誘導ナビゲーション市場 - 製品(ワークステーション、ソフトウェア、ナビゲーター)、治療領域(神経学、耳鼻咽喉科)、ナビゲーションの種類(光学、電子顕微鏡)、ケア環境(インターベンショナルラジオロジースイート、外科)、参照モダリティ、エンドユーザー - 2030年までの世界予測
Image-guided Navigation Market by Product (Workstation, Software, Navigator), Therapy Area (Neurology, ENT), Type of Navigation (Optical, EM), Care Setting (Interventional Radiology Suite, Surgical), Reference Modality, End User - Global Forecast to 2030

商品番号 : SMB-77814

出版社MarketsandMarkets
出版年月2025年5月
ページ数342
図表数392
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

本レポートは、画像誘導ナビゲーション市場を、製品タイプ、ケア環境、治療領域、ナビゲーションの種類、参照モダリティの種類、エンドユーザー、地域に基づいて分析しています。また、市場の成長に影響を与える要因(促進要因、抑制要因、機会、課題など)についても分析しています。市場における機会と課題を分析し、市場リーダーの競争環境の詳細を提供します。さらに、ミクロ市場を個々の成長傾向の観点から分析し、5つの主要地域とそれぞれの国における市場セグメントの収益予測を示しています。

Report Overview

The global image-guided navigation market is projected to grow from USD 2,545.6 million in 2025 to USD 3,912.5 million by 2030, at a CAGR of 9.0%, during the forecast period. Advanced medical systems, such as image-guided navigation, enhance surgical precision by integrating real-time visual guidance through modalities such as CT, MRI, and ultrasound; this integration minimizes complication rates, accelerates recovery periods, and optimizes patient outcomes.

世界の画像誘導ナビゲーション市場は、予測期間中に2025年の25億4,560万米ドルから2030年には39億1,250万米ドルに拡大し、年平均成長率(CAGR)9.0%で成長すると予測されています。画像誘導ナビゲーションなどの高度な医療システムは、CT、MRI、超音波などのモダリティを通じたリアルタイムの視覚誘導を統合することで、手術の精度を向上させます。この統合により、合併症発生率の最小化、回復期間の短縮、そして患者の転帰の最適化が実現します。

The market for these technologies is expanding, propelled by the increasing demand for MIS techniques and the widespread adoption of imaging modalities within operating theaters. Furthermore, the necessity for heightened accuracy in complex surgical interventions, particularly in neurosurgery, orthopedics, and otolaryngology, drives market growth. As healthcare institutions increasingly emphasize safety and operational efficiency, image-guided surgical systems are becoming integral to contemporary surgical practices.

これらの技術の市場は、MIS技術の需要増加と手術室における画像診断装置の普及に牽引され、拡大しています。さらに、特に脳神経外科、整形外科、耳鼻咽喉科における複雑な外科的介入における高い精度の必要性が、市場の成長を牽引しています。医療機関が安全性と業務効率を重視するようになるにつれ、画像誘導手術システムは現代の外科治療に不可欠なものになりつつあります。

画像誘導ナビゲーション市場 - 2030年までの世界予測
image-guided-navigation-market-Overview

By care setting, the surgical segment is projected to grow at the highest CAGR during the forecast period.

Between 2025 and 2030, the surgical segment is anticipated to witness the most substantial growth within the image-guided navigation market. This high market growth can be attributed to the ongoing integration of navigation systems into real-time intraoperative workflows. The development of hybrid operating rooms has facilitated a seamless integration of image-guided platforms with surgical microscopes, C-arms, and robotic systems, thereby enhancing the efficiency of intricate procedures such as brain tumor resections and spinal fusions. Moreover, there is a notable increase in demand for intraoperative CT and MRI-compatible navigation systems, particularly in neurosurgery and orthopedics, where dynamic imaging capabilities significantly boost surgical accuracy. Hospitals are increasingly focusing on navigated instrumentation to minimize operative durations and protect critical anatomical structures, especially in ENT and skull base surgeries. This rising procedural demand, coupled with recent regulatory approvals for navigation-integrated surgical tools, has propelled adoption rates specifically within surgical suites rather than in pre-operative or outpatient environments.

By type of navigation, the optical navigation segment accounted for the largest market share in 2024.

In 2024, the optical navigation segment emerged as the predominant driver of market share within the image-guided navigation landscape, largely owing to its superior line-of-sight accuracy and exceptional spatial resolution, parameters of paramount importance in neurosurgical and spinal procedures. Unlike electromagnetic systems, optical navigation remains impervious to metallic interference from surgical instrumentation, thereby ensuring consistently precise tracking capabilities within intricate operative environments. The incorporation of active infrared markers in optical systems facilitates real-time feedback with sub-millimeter precision, which helps navigate during minimally invasive interventions. The increasing adoption of ceiling-mounted and portable optical tracking systems within hybrid operating suites has significantly enhanced their intraoperative functionality. Moreover, the compatibility of these optical systems with advanced 3D imaging software has solidified their status as the most dependable navigation modality in high-stakes surgical domains. This comprehensive integration underscores the pivotal role of optical navigation in optimizing surgical outcomes.

The Asia Pacific region is expected to witness the highest growth rate during the forecast period.

The Asia Pacific region is poised for significant growth in the image-guided navigation market from 2025 to 2030, driven by a surge in advanced surgical procedures in countries such as China, India, and South Korea. Strategic government initiatives aimed at enhancing hospital infrastructure, coupled with increased investments in robotic and image-guided surgical technologies, have propelled the demand for these navigation systems. Moreover, the proliferation of specialized neurosurgical and orthopedic centers, alongside the heightened awareness of the benefits of MIS techniques, is facilitating broader adoption of these systems. The local manufacturing and distribution efforts by regional companies have further enhanced the accessibility and affordability of image-guided navigation technologies in emerging markets. This convergence of factors is likely to establish the Asia Pacific as a key player in the advancement of image-guided surgical solutions.

Breakdown of supply-side primary interviews:

  • •By Company Type: Tier 1—45%, Tier 2—20%, and Tier 3—35%
  • •By Designation: C-level—35%, Director-level—25%, and Other designations—40%
  • •By Region: North America—40%, Europe—25%, Asia Pacific—20%, Latin America—10%, Middle East & Africa—5%

Breakdown of demand-side primary interviews:

  • •By Company Type: Hospitals—60%, Ambulatory Surgery Centers—25%, and Diagnostics Imaging Centers—15%
  • •By Designation: Directors—35%, Vice Presidents—27%, Managers—22%, and Other Designations—16%
  • •By Region: North America—40%, Europe—25%, Asia Pacific—20%, Latin America—10%, Middle East & Africa—5%
画像誘導ナビゲーション市場 - 2030年までの世界予測 ecosystem
image-guided-navigation-market-Ecosystem

Research Coverage

This report studies the image-guided navigation market based on product type, care setting, therapy area, type of navigation, reference modality type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and respective countries.

Reasons to Buy the Report

The report serves as a valuable resource for both established enterprises and emerging or smaller firms to effectively assess market dynamics. This insight will enable them to capture a larger market share. Organizations that invest in the report can employ one or a combination of the following five strategic approaches.

This report provides insights into the following pointers:

  • Analysis of key drivers (growing adoption of minimally invasive surgical procedures, rising uptake of robotics in surgeries, high government investments, funds, and grants for minimally invasive surgical procedures, increasing applications of image-guided navigation across medical specialties), restraints (High cost of image-guided navigation systems in surgical and interventional procedures, Lack of system accuracy and reliability), opportunities (Rising investments in healthcare AI and big data analytics, Increasing partnerships and collaborations among key players), and challenges (Rising number of product recalls, Limited adoption of image-guided navigation surgeries in emerging economies) influencing the growth of image-guided navigation market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the image-guided navigation market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of image-guided navigation procedures across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the image-guided navigation market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the image-guided navigation market.

Table of Contents

1               INTRODUCTION              30

1.1           STUDY OBJECTIVES       30

1.2           MARKET DEFINITION   30

1.3           STUDY SCOPE   31

1.3.1        SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE                 31

1.3.2        INCLUSIONS & EXCLUSIONS       32

1.3.3        YEARS CONSIDERED      33

1.3.4        CURRENCY CONSIDERED            33

1.4           STAKEHOLDERS               34

2               RESEARCH METHODOLOGY       35

2.1           RESEARCH DATA              35

2.1.1        SECONDARY DATA          35

2.1.1.1    Key sources of secondary data            36

2.1.1.2    Key data from secondary sources       37

2.1.2        PRIMARY DATA 37

2.1.2.1    Key objectives of primary research    38

2.1.2.2    Key data from primary sources           39

2.1.2.3    Insights from primary experts             40

2.2           MARKET SIZE ESTIMATION         42

2.2.1        REVENUE SHARE ANALYSIS (SUPPLY SIDE)          42

2.2.2        TOP-DOWN APPROACH                43

2.2.3        DEMAND-SIDE APPROACH          44

2.2.4        VOLUME DATA ANALYSIS            45

2.3           DATA TRIANGULATION                48

2.4           MARKET SHARE ANALYSIS           48

2.5           STUDY ASSUMPTIONS  49

2.6           RESEARCH LIMITATIONS             49

2.7           RISK ANALYSIS  50

3               EXECUTIVE SUMMARY  51

4               PREMIUM INSIGHTS       56

4.1           IMAGE-GUIDED NAVIGATION MARKET OVERVIEW                 56

4.2           NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT AND COUNTRY, 2024      57

4.3           IMAGE-GUIDED NAVIGATION MARKET: REGIONAL MIX                 57

4.4           IMAGE-GUIDED NAVIGATION MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES      58

4.5           IMAGE-GUIDED NAVIGATION MARKET: EMERGING VS. DEVELOPED MARKETS 59

5               MARKET OVERVIEW       60

5.1           INTRODUCTION              60

5.2           MARKET DYNAMICS       61

5.2.1        DRIVERS               61

5.2.1.1    Growing adoption of minimally invasive surgical procedures                 61

5.2.1.2    Rising uptake of robotics in surgeries                62

5.2.1.3    High government investments, funds, and grants for minimally invasive surgeries 63

5.2.1.4    Increasing applications of image-guided navigation across medical specialties                65

5.2.2        RESTRAINTS      66

5.2.2.1    High cost of image-guided navigation systems in surgical and interventional procedures   66

5.2.2.2    Lack of system accuracy and reliability             66

5.2.3        OPPORTUNITIES              67

5.2.3.1    Rising investments in healthcare AI and big data analytics                 67

5.2.3.2    Increasing partnerships and collaborations among large industry players    68

5.2.4        CHALLENGES    69

5.2.4.1    Rising number of product recalls       69

5.2.4.2    Limited adoption of image-guided navigation surgeries in emerging economies             69

5.3           TECHNOLOGY ANALYSIS             70

5.3.1        KEY TECHNOLOGIES     70

5.3.1.1    AI-based image analysis      70

5.3.1.2    Robot-assisted navigation   70

5.3.2        COMPLEMENTARY TECHNOLOGIES       71

5.3.2.1    Patient-specific 3D modelling            71

5.3.2.2    Cloud-based and remote navigation  71

5.4           PORTER’S FIVE FORCES ANALYSIS           71

5.4.1        INTENSITY OF COMPETITIVE RIVALRY 72

5.4.2        BARGAINING POWER OF BUYERS             73

5.4.3        BARGAINING POWER OF SUPPLIERS       73

5.4.4        THREAT OF SUBSTITUTES          73

5.4.5        THREAT OF NEW ENTRANTS      73

5.5           KEY STAKEHOLDERS & BUYING CRITERIA            74

5.5.1        KEY STAKEHOLDERS IN BUYING PROCESS           74

5.5.2        KEY BUYING CRITERIA  75

5.6           REGULATORY ANALYSIS               75

5.6.1        REGULATORY LANDSCAPE         75

5.6.1.1    North America      75

5.6.1.1.1 US           75

5.6.1.2    Europe   77

5.6.1.3    Asia Pacific            77

5.6.1.3.1 Japan      77

5.6.1.3.2 China      78

5.6.1.3.3 India       79

5.6.1.4    Latin America       79

5.6.1.4.1 Brazil      79

5.6.1.5    Middle East & Africa            79

5.6.1.5.1 UAE        79

5.6.2        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             80

5.7           PATENT ANALYSIS          81

5.7.1        INSIGHTS ON PATENT PUBLICATION TRENDS

(TOP APPLICANTS/JURISDICTION)         81

5.7.2        LIST OF MAJOR PATENTS, 2023–2025        83

5.8           TRADE ANALYSIS             84

5.8.1        IMPORT DATA FOR HS CODE 901820, 2020–2024  84

5.8.2        EXPORT DATA FOR HS CODE 901820, 2020–2024  85

5.9           PRICING ANALYSIS          86

5.9.1        AVERAGE SELLING PRICE TREND OF IMAGE-GUIDED NAVIGATION PRODUCTS, BY KEY PLAYER, 2022–2024      86

5.9.2        AVERAGE SELLING PRICE TREND OF IMAGE-GUIDED NAVIGATION PRODUCTS, BY REGION, 2022–2024               87

5.10         KEY CONFERENCES & EVENTS, 2025–2026              87

5.11         UNMET NEEDS/END-USER EXPECTATIONS         88

5.12         VALUE CHAIN ANALYSIS               89

5.13         SUPPLY CHAIN ANALYSIS             90

5.14         ECOSYSTEM ANALYSIS  91

5.15         CASE STUDY ANALYSIS 92

5.15.1      BRAINLAB’S SMART NAVIGATION SYSTEM TO IMPROVE BRAIN TUMOR SURGERY              92

5.15.2      ZIMMER BIOMET’S ROBOTIC NAVIGATION TO ASSIST MINIMALLY INVASIVE JOINT REPLACEMENT SURGERIES                 92

5.15.3      MEDTRONIC’S PRECISION NAVIGATION SYSTEM TO CONDUCT ADVANCED SPINE SURGERIES            93

5.16         ADJACENT MARKET ANALYSIS  93

5.17         TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS            94

5.18         INVESTMENT & FUNDING SCENARIO     94

5.19         IMPACT OF AI/GEN AI ON IMAGE-GUIDED NAVIGATION MARKET               95

5.20         IMPACT OF 2025 US TARIFF ON IMAGE-GUIDED NAVIGATION MARKET  95

5.20.1      INTRODUCTION              95

5.20.2      KEY TARIFF RATES          96

5.20.3      PRICE IMPACT ANALYSIS             97

5.20.4      IMPACT ON COUNTRY/REGION                97

5.20.4.1  North America      97

5.20.4.1.1                US           97

5.20.4.2  Europe   97

5.20.4.3  Asia Pacific            98

5.20.5      IMPACT ON END-USE INDUSTRIES          98

5.20.5.1  Hospitals                98

5.20.5.2  Ambulatory surgery centers                98

5.20.5.3  Diagnostic imaging centers 98

6               IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT                 99

6.1           INTRODUCTION              100

6.2           WORKSTATIONS & SOFTWARE  100

6.2.1        DEMAND FOR ADVANCED SURGICAL PLANNING TOOLS AND REAL-TIME INTRAOPERATIVE NAVIGATION SYSTEMS TO DRIVE MARKET      100

6.3           NAVIGATORS    103

6.3.1        PREVALENCE OF COMPLEX MEDICAL CONDITIONS REQUIRING PRECISE SURGICAL INTERVENTIONS TO AUGMENT MARKET GROWTH          103

6.4           CONSUMABLES 105

6.4.1        INCREASING POPULARITY OF MINIMALLY INVASIVE SURGERIES TO BOOST DEMAND FOR CONSUMABLES   105

7               IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING              107

7.1           INTRODUCTION              108

7.2           INTERVENTIONAL RADIOLOGY SUITE  108

7.2.1        GROWING INTEGRATION OF HYBRID OPERATING ROOMS WITH ADVANCED IMAGING CAPABILITIES TO SUPPORT MARKET GROWTH     108

7.3           SURGICAL           110

7.3.1        SURGICAL NAVIGATION SYSTEMS TO MINIMIZE TISSUE DAMAGE AND ENABLE MORE TARGETED INTERVENTIONS                 110

7.4           OTHER CARE SETTINGS                111

8               IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA     113

8.1           INTRODUCTION              114

8.2           ONCOLOGY        115

8.2.1        INCREASING INCIDENCE OF CANCER TO DRIVE MARKET               115

8.3           NEUROLOGY     117

8.3.1        NEED FOR HIGH PRECISION IN BRAIN AND SPINAL SURGERIES TO SUPPORT MARKET GROWTH      117

8.4           ENT        119

8.4.1        INCREASING INCIDENCE OF COMPLEX ENT-RELATED INJURIES AND DISEASES TO FAVOR MARKET GROWTH 119

8.5           PULMONARY     121

8.5.1        HIGH BURDEN OF LUNG CANCER TO SPUR MARKET GROWTH             121

8.6           GASTROENTEROLOGY 123

8.6.1        INCREASED PREVALENCE OF COLORECTAL CANCER TO AUGMENT MARKET GROWTH            123

8.7           MUSCULOSKELETAL      125

8.7.1        RISING MUSCULOSKELETAL SURGICAL VOLUME TO FAVOR MARKET GROWTH           125

8.8           DENTAL               127

8.8.1        IMAGE-GUIDED DENTAL NAVIGATION SYSTEMS TO FACILITATE MINIMALLY-INVASIVE PROCEDURES AND ENHANCE PATIENT RECOVERY 127

8.9           CARDIOVASCULAR          129

8.9.1        HIGH PREVALENCE OF CARDIOVASCULAR DISEASES TO AID MARKET GROWTH 129

8.10         OTHER THERAPY AREAS               131

9               IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION     133

9.1           INTRODUCTION              134

9.2           OPTICAL NAVIGATION 134

9.2.1        HIGH PRECISION AND SEAMLESS INTEGRATION WITH IMAGING MODALITIES TO AID ADOPTION IN SURGICAL APPLICATIONS 134

9.3           ELECTROMAGNETIC NAVIGATION         137

9.3.1        TECHNOLOGICAL ADVANCEMENTS AND AVAILABILITY OF HIGH-PRECISION GUIDANCE TO PROPEL MARKET GROWTH          137

9.4           ROBOTIC-ASSISTED TRACKING AND AUGMENTED REALITY & MIXED REALITY NAVIGATION             139

9.4.1        GROWING REQUIREMENT FOR ADVANCED VISUALIZATION AND PRECISION IN COMPLEX SURGERIES TO DRIVE MARKET 139

10            IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE              141

10.1         INTRODUCTION              142

10.2         CT-BASED REFERENCE 142

10.2.1      WIDESPREAD CLINICAL USE AND DIAGNOSTIC ACCURACY OF CT SCANS TO PROPEL MARKET GROWTH                 142

10.3         FLUOROSCOPY-BASED REFERENCE        144

10.3.1      ADVANCEMENTS IN FLUOROSCOPY TECHNOLOGY FOR COMPLEX SURGERIES TO AUGMENT MARKET GROWTH                 144

10.4         MRI-BASED REFERENCE                146

10.4.1      SUPERIOR IMAGING CAPABILITIES TO ACCELERATE MARKET GROWTH          146

10.5         ULTRASOUND-BASED REFERENCE          148

10.5.1      TECHNOLOGICAL ADVANCEMENTS TO FUEL UPTAKE OF ULTRASOUND-BASED REFERENCE IN POINT-OF-CARE APPLICATIONS 148

10.6         OTHER REFERENCE MODALITY TYPES  150

11            IMAGE-GUIDED NAVIGATION MARKET, BY END USER                 151

11.1         INTRODUCTION              152

11.2         HOSPITALS         152

11.2.1      BETTER RESOURCE AND COST MANAGEMENT TO FAVOR MARKET GROWTH           152

11.3         AMBULATORY SURGERY CENTERS          154

11.3.1      COST-EFFECTIVENESS AND IMPROVED PATIENT CONVENIENCE TO FAVOR MARKET GROWTH   154

11.4         DIAGNOSTIC IMAGING CENTERS             156

11.4.1      DIAGNOSTIC IMAGING CENTERS TO INTEGRATE IMAGE-GUIDED NAVIGATION SYSTEMS FOR IMPROVED PROCEDURAL OUTCOMES          156

12            IMAGE-GUIDED NAVIGATION MARKET, BY REGION                 158

12.1         INTRODUCTION              159

12.2         NORTH AMERICA             160

12.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 160

12.2.2      US           165

12.2.2.1  US to dominate North American image-guided navigation market during forecast period             165

12.2.3      CANADA               168

12.2.3.1  High government investments in digital research infrastructure to propel market growth      168

12.3         EUROPE               172

12.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      172

12.3.2      GERMANY           176

12.3.2.1  Strong healthcare infrastructure and demand for advanced surgical technologies to augment market growth             176

12.3.3      UK          180

12.3.3.1  High burden of complex diseases and well-developed public healthcare system to fuel market growth           180

12.3.4      FRANCE                183

12.3.4.1  Increased demand for minimally invasive surgeries and favorable government investments in digital health to aid market growth   183

12.3.5      ITALY    187

12.3.5.1  Strong network of public and private hospitals and high prevalence of complex diseases to propel market growth               187

12.3.6      SPAIN    190

12.3.6.1  Advancements in healthcare infrastructure to boost market growth    190

12.3.7      REST OF EUROPE             193

12.4         ASIA PACIFIC     197

12.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 197

12.4.2      CHINA  202

12.4.2.1  Large patient population and favorable government initiatives to fuel adoption during surgeries            202

12.4.3      JAPAN   206

12.4.3.1  High geriatric population and universal reimbursement policy for standardized healthcare services to drive market            206

12.4.4      INDIA    209

12.4.4.1  Availability of skilled medical professionals to augment market growth    209

12.4.5      SOUTH KOREA  213

12.4.5.1  Advanced healthcare infrastructure and increased popularity of robot-assisted surgeries to fuel market growth                 213

12.4.6      AUSTRALIA         216

12.4.6.1  Rising burden of neurological and spinal disorders to fuel uptake of image-guided navigation products                216

12.4.7      REST OF ASIA PACIFIC   220

12.5         LATIN AMERICA                223

12.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 223

12.5.2      BRAZIL 227

12.5.2.1  Increased government healthcare budget and favorable regulatory policies to support market growth  227

12.5.3      MEXICO                230

12.5.3.1  Nearshoring of medical device manufacturing to propel market growth    230

12.5.4      ARGENTINA       234

12.5.4.1  High government healthcare investments and increased prevalence of chronic diseases to drive market                234

12.5.5      REST OF LATIN AMERICA             237

12.6         MIDDLE EAST & AFRICA                240

12.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 241

12.6.2      GCC COUNTRIES              244

12.6.2.1  Increased government investments in medical sector to spur market growth       244

12.6.3      REST OF MIDDLE EAST & AFRICA             247

13            COMPETITIVE LANDSCAPE         251

13.1         INTRODUCTION              251

13.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            251

13.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IMAGE-GUIDED NAVIGATION MARKET           251

13.3         REVENUE ANALYSIS, 2020–2024  253

13.4         MARKET SHARE ANALYSIS, 2024                 254

13.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 257

13.5.1      STARS   257

13.5.2      EMERGING LEADERS     257

13.5.3      PERVASIVE PLAYERS      257

13.5.4      PARTICIPANTS 257

13.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         259

13.5.5.1  Company footprint               259

13.5.5.2  Region footprint   260

13.5.5.3  Product footprint  261

13.5.5.4  Care setting footprint           261

13.5.5.5  Therapy area footprint         262

13.5.5.6  Type of navigation footprint               263

13.5.5.7  Reference modality type footprint     264

13.6         COMPANY EVALUATION MATRIX: STARTUPS/ SMES, 2024        265

13.6.1      PROGRESSIVE COMPANIES         265

13.6.2      RESPONSIVE COMPANIES            265

13.6.3      DYNAMIC COMPANIES  265

13.6.4      STARTING BLOCKS         265

13.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 267

13.6.5.1  Detailed list of key startups/SME players         267

13.6.5.2  Competitive benchmarking of startups/SME players     268

13.7         COMPANY VALUATION & FINANCIAL METRICS 269

13.7.1      FINANCIAL METRICS      269

13.7.2      COMPANY VALUATION 269

13.8         BRAND/PRODUCT COMPARISON             270

13.9         R&D ASSESSMENT OF KEY PLAYERS        271

13.10       COMPETITIVE SCENARIO             271

13.10.1   PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS                 271

13.10.2   DEALS  272

13.10.3   EXPANSIONS     274

14            COMPANY PROFILES      275

14.1         KEY PLAYERS     275

14.1.1      MEDTRONIC      275

14.1.1.1  Business overview 275

14.1.1.2  Products/Services/Solutions offered 276

14.1.1.3  Recent developments           277

14.1.1.3.1                Product launches  277

14.1.1.3.2                Deals      278

14.1.1.3.3                Expansions             278

14.1.1.4  MnM view              279

14.1.1.4.1                Key strengths        279

14.1.1.4.2                Strategic choices   279

14.1.1.4.3                Weaknesses & competitive threats     279

14.1.2      BRAINLAB AG    280

14.1.2.1  Business overview 280

14.1.2.2  Products/Services/Solutions offered 280

14.1.2.3  Recent developments           281

14.1.2.3.1                Product approvals 281

14.1.2.3.2                Deals      282

14.1.2.4  MnM view              282

14.1.2.4.1                Key strengths        282

14.1.2.4.2                Strategic choices   283

14.1.2.4.3                Weaknesses & competitive threats     283

14.1.3      STRYKER              284

14.1.3.1  Business overview 284

14.1.3.2  Products/Services/Solutions offered 285

14.1.3.3  Recent developments           286

14.1.3.3.1                Product approvals 286

14.1.3.4  MnM view              287

14.1.3.4.1                Key strengths        287

14.1.3.4.2                Strategic choices   287

14.1.3.4.3                Weaknesses & competitive threats     287

14.1.4      B. BRAUN SE       288

14.1.4.1  Business overview 288

14.1.4.2  Products/Services/Solutions offered 289

14.1.4.3  Recent developments           290

14.1.4.3.1                Deals      290

14.1.4.4  MnM view              291

14.1.4.4.1                Right to win           291

14.1.4.4.2                Strategic choices   291

14.1.4.4.3                Weaknesses & competitive threats     291

14.1.5      KONINKLIJKE PHILIPS N.V.          292

14.1.5.1  Business overview 292

14.1.5.2  Products/Services/Solutions offered 293

14.1.5.3  Recent developments           294

14.1.5.3.1                Product launches  294

14.1.5.4  MnM view              295

14.1.5.4.1                Key strengths        295

14.1.5.4.2                Strategic choices   295

14.1.5.4.3                Weaknesses & competitive threats     295

14.1.6      GE HEALTHCARE             296

14.1.6.1  Business overview 296

14.1.6.2  Products/Services/Solutions offered 297

14.1.6.3  Recent developments           298

14.1.6.3.1                Product approvals 298

14.1.6.3.2                Deals      298

14.1.7      OLYMPUS CORPORATION           299

14.1.7.1  Business overview 299

14.1.7.2  Products/Services/Solutions offered 300

14.1.7.3  Recent developments           301

14.1.7.3.1                Deals      301

14.1.8      SMITH+NEPHEW              302

14.1.8.1  Business overview 302

14.1.8.2  Products/Services/Solutions offered 303

14.1.8.3  Recent development             303

14.1.8.3.1                Deals      303

14.1.9      JOHNSON & JOHNSON SERVICES, INC.   304

14.1.9.1  Business overview 304

14.1.9.2  Products/Services/Solutions offered 305

14.1.9.3  Recent development             306

14.1.9.3.1                Deals      306

14.1.10   GLOBUS MEDICAL (NUVASIVE) 307

14.1.10.1                 Business overview 307

14.1.10.2                 Products/Services/Solutions offered 308

14.1.10.3                 Recent development             309

14.1.10.3.1             Deals      309

14.1.11   STEREOTAXIS, INC.         310

14.1.11.1                 Business overview 310

14.1.11.2                 Products/Services/Solutions offered 311

14.1.11.3                 Recent developments           311

14.1.11.3.1             Product approvals 311

14.1.11.3.2             Deals      312

14.1.12   ORTHOFIX MEDICAL INC.            313

14.1.12.1                 Business overview 313

14.1.12.2                 Products/Services/Solutions offered 314

14.1.12.3                 Recent developments           315

14.1.12.3.1             Deals      315

14.1.13   INTEGRA LIFESCIENCES CORPORATION               316

14.1.13.1                 Business overview 316

14.1.13.2                 Products/Services/Solutions offered 317

14.1.13.3                 Recent developments           318

14.1.13.3.1             Deals      318

14.1.14   ZIMMER BIOMET             319

14.1.14.1                 Business overview 319

14.1.14.2                 Products/Services/Solutions offered 320

14.1.14.3                 Recent developments           321

14.1.14.3.1             Deals      321

14.1.15   INTUITIVE SURGICAL    322

14.1.15.1                 Business overview 322

14.1.15.2                 Products/Services/Solutions offered 323

14.1.15.3                 Recent developments           323

14.1.15.3.1             Other developments             323

14.2         OTHER PLAYERS              324

14.2.1      KARL STORZ      324

14.2.2      FIAGON GMBH 325

14.2.3      ZETA SURGICAL INC.     326

14.2.4      BRAIN NAVI BIOTECHNOLOGY CO., LTD.             327

14.2.5      IMAGE NAVIGATION, LTD.          328

14.2.6      HAPPY RELIABLE SURGERIES PVT. LTD.                329

14.2.7      RXOOM HEALTHCARE PVT. LTD.              330

14.2.8      CLARONAV         331

14.2.9      SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.                 331

14.2.10   ZIEHM IMAGING GMBH                 332

15            APPENDIX           333

15.1         DISCUSSION GUIDE        333

15.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                338

15.3         CUSTOMIZATION OPTIONS        340

15.4         RELATED REPORTS         340

15.5         AUTHOR DETAILS           341

LIST OF TABLES

TABLE 1                IMAGE-GUIDED NAVIGATION MARKET: INCLUSIONS & EXCLUSIONS       32

TABLE 2                STANDARD CURRENCY EXCHANGE RATES, 2021–2024 (USD)                33

TABLE 3                IMAGE-GUIDED NAVIGATION MARKET: STUDY ASSUMPTIONS  49

TABLE 4                IMAGE-GUIDED NAVIGATION MARKET: RISK ANALYSIS            50

TABLE 5                MAJOR FUNDING BY GOVERNMENT BODIES, 2021–2024              64

TABLE 6                PROJECTS FUNDED BY NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING, 2024                 64

TABLE 7                IMAGE-GUIDED NAVIGATION MARKET: PORTER’S FIVE FORCES 71

TABLE 8                INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT               74

TABLE 9                KEY BUYING CRITERIA FOR IMAGE-GUIDED NAVIGATION SYSTEMS, BY END USER    75

TABLE 10              US FDA: CLASSIFICATION OF MEDICAL DEVICES                 76

TABLE 11              US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              76

TABLE 12              JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY (PMDA)                 78

TABLE 13              CHINA: CLASSIFICATION OF MEDICAL DEVICES                 78

TABLE 14              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 80

TABLE 15              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           80

TABLE 16              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 81

TABLE 17              IMAGE-GUIDED NAVIGATION MARKET: LIST OF MAJOR PATENTS,

JANUARY 2023–MARCH 2025         83

TABLE 18              IMPORT DATA FOR HS CODE 901820, BY COUNTRY,

2020–2024 (USD THOUSAND)      85

TABLE 19              EXPORT DATA FOR HS CODE 901820, BY COUNTRY,

2020–2024 (USD THOUSAND)      85

TABLE 20              AVERAGE SELLING PRICE TREND OF IMAGE-GUIDED NAVIGATION PRODUCTS,

BY KEY PLAYER, 2022–2024 (USD)              86

TABLE 21              AVERAGE SELLING PRICE TREND OF IMAGE-GUIDED NAVIGATION PRODUCTS,

BY REGION, 2022–2024 (USD)      87

TABLE 22              IMAGE-GUIDED NAVIGATION MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025−DECEMBER 2026   87

TABLE 23              IMAGE-GUIDED NAVIGATION MARKET: UNMET NEEDS/END-USER EXPECTATIONS          88

TABLE 24              CASE STUDY 1: BRAINLAB’S SMART NAVIGATION SYSTEM TO IMPROVE BRAIN TUMOR SURGERY                 92

TABLE 25              CASE STUDY 2: ZIMMER BIOMET’S ROBOTIC NAVIGATION TO ASSIST MINIMALLY INVASIVE JOINT REPLACEMENT SURGERIES         92

TABLE 26              CASE STUDY 3: MEDTRONIC’S PRECISION NAVIGATION SYSTEM TO CONDUCT ADVANCED SPINE SURGERIES         93

TABLE 27              IMAGE-GUIDED NAVIGATION MARKET: IMPACT OF AI/GEN AI   95

TABLE 28              US: ADJUSTED RECIPROCAL TARIFF RATES                 96

TABLE 29              IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     100

TABLE 30              KEY WORKSTATIONS & SOFTWARE AVAILABLE IN IMAGE-GUIDED

NAVIGATION MARKET  101

TABLE 31              IMAGE-GUIDED NAVIGATION MARKET FOR WORKSTATIONS & SOFTWARE,

BY COUNTRY, 2023–2030 (USD MILLION)               102

TABLE 32              KEY NAVIGATORS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET                103

TABLE 33              IMAGE-GUIDED NAVIGATION MARKET FOR NAVIGATORS, BY COUNTRY,

2023–2030 (USD MILLION)            104

TABLE 34              KEY CONSUMABLES AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET                105

TABLE 35              IMAGE-GUIDED NAVIGATION MARKET FOR CONSUMABLES, BY COUNTRY,

2023–2030 (USD MILLION)            106

TABLE 36              IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            108

TABLE 37              IMAGE-GUIDED NAVIGATION MARKET FOR INTERVENTIONAL RADIOLOGY SUITE,

BY COUNTRY, 2023–2030 (USD MILLION)               109

TABLE 38              IMAGE-GUIDED NAVIGATION MARKET FOR SURGICAL, BY COUNTRY,

2023–2030 (USD MILLION)            111

TABLE 39              IMAGE-GUIDED NAVIGATION MARKET FOR OTHER CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)            112

TABLE 40              IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            114

TABLE 41              KEY ONCOLOGY PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 115

TABLE 42              IMAGE-GUIDED NAVIGATION MARKET FOR ONCOLOGY, BY COUNTRY,

2023–2030 (USD MILLION)            116

TABLE 43              KEY NEUROLOGY PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 117

TABLE 44              IMAGE-GUIDED NAVIGATION MARKET FOR NEUROLOGY, BY COUNTRY,

2023–2030 (USD MILLION)            118

TABLE 45              KEY ENT PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET                119

TABLE 46              IMAGE-GUIDED NAVIGATION MARKET FOR ENT, BY COUNTRY,

2023–2030 (USD MILLION)            120

TABLE 47              KEY PULMONARY PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 121

TABLE 48              IMAGE-GUIDED NAVIGATION MARKET FOR PULMONARY, BY COUNTRY,

2023–2030 (USD MILLION)            122

TABLE 49              KEY GASTROENTEROLOGY PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET  123

TABLE 50              IMAGE-GUIDED NAVIGATION MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)                 124

TABLE 51              KEY MUSCULOSKELETAL PRODUCTS AVAILABLE IN IMAGE-GUIDED

NAVIGATION MARKET  125

TABLE 52              IMAGE-GUIDED NAVIGATION MARKET FOR MUSCULOSKELETAL, BY COUNTRY, 2023–2030 (USD MILLION)                 126

TABLE 53              KEY DENTAL PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET                127

TABLE 54              IMAGE-GUIDED NAVIGATION MARKET FOR DENTAL, BY COUNTRY,

2023–2030 (USD MILLION)            128

TABLE 55              KEY CARDIOVASCULAR PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET           129

TABLE 56              IMAGE-GUIDED NAVIGATION MARKET FOR CARDIOVASCULAR, BY COUNTRY,

2023–2030 (USD MILLION)            130

TABLE 57              KEY OTHER THERAPY PRODUCTS AVAILABLE IN IMAGE-GUIDED

NAVIGATION MARKET  131

TABLE 58              IMAGE-GUIDED NAVIGATION MARKET FOR OTHER THERAPY AREAS, BY COUNTRY, 2023–2030 (USD MILLION)            132

TABLE 59              IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            134

TABLE 60              KEY OPTICAL NAVIGATION PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET  135

TABLE 61              IMAGE-GUIDED OPTICAL NAVIGATION MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            136

TABLE 62              KEY ELECTROMAGNETIC NAVIGATION PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET               137

TABLE 63              IMAGE-GUIDED ELECTROMAGNETIC NAVIGATION MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            138

TABLE 64              KEY ROBOTIC-ASSISTED TRACKING AND AUGMENTED REALITY & MIXED REALITY NAVIGATION PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET               139

TABLE 65              IMAGE-GUIDED ROBOTIC-ASSISTED TRACKING AND AUGMENTED REALITY & MIXED REALITY NAVIGATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 140

TABLE 66              IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE,

2023–2030 (USD MILLION)            142

TABLE 67              IMAGE-GUIDED NAVIGATION MARKET FOR CT-BASED REFERENCE, BY COUNTRY, 2023–2030 (USD MILLION)                 143

TABLE 68              IMAGE-GUIDED NAVIGATION MARKET FOR FLUOROSCOPY-BASED REFERENCE,

BY COUNTRY, 2023–2030 (USD MILLION)               145

TABLE 69              IMAGE-GUIDED NAVIGATION MARKET FOR MRI-BASED REFERENCE, BY COUNTRY, 2023–2030 (USD MILLION)            147

TABLE 70              IMAGE-GUIDED NAVIGATION MARKET FOR ULTRASOUND-BASED REFERENCE,

BY COUNTRY, 2023–2030 (USD MILLION)               149

TABLE 71              IMAGE-GUIDED NAVIGATION MARKET FOR OTHER REFERENCE MODALITY TYPES, BY COUNTRY, 2023–2030 (USD MILLION) 150

TABLE 72              IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION)                152

TABLE 73              IMAGE-GUIDED NAVIGATION MARKET FOR HOSPITALS, BY COUNTRY,

2023–2030 (USD MILLION)            153

TABLE 74              IMAGE-GUIDED NAVIGATION MARKET FOR AMBULATORY SURGERY CENTERS,

BY COUNTRY, 2023–2030 (USD MILLION)               155

TABLE 75              IMAGE-GUIDED NAVIGATION MARKET FOR DIAGNOSTIC IMAGING CENTERS,

BY COUNTRY, 2023–2030 (USD MILLION)               157

TABLE 76              IMAGE-GUIDED NAVIGATION MARKET, BY REGION, 2023–2030 (USD MILLION)          160

TABLE 77              NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            162

TABLE 78              NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            162

TABLE 79              NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (UNITS SOLD)               162

TABLE 80              NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            163

TABLE 81              NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            163

TABLE 82              NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 164

TABLE 83              NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)       164

TABLE 84              NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            165

TABLE 85              US: KEY MACROINDICATORS     166

TABLE 86              US: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            166

TABLE 87              US: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            166

TABLE 88              US: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            167

TABLE 89              US: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            167

TABLE 90              US: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE,

2023–2030 (USD MILLION)            168

TABLE 91              US: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            168

TABLE 92              CANADA: KEY MACROINDICATORS         169

TABLE 93              CANADA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            169

TABLE 94              CANADA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            170

TABLE 95              CANADA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            170

TABLE 96              CANADA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            171

TABLE 97              CANADA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)            171

TABLE 98              CANADA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            172

TABLE 99              EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            173

TABLE 100            EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            173

TABLE 101            EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (UNITS SOLD)               174

TABLE 102            EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            174

TABLE 103            EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            175

TABLE 104            EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            175

TABLE 105            EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)            176

TABLE 106            EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            176

TABLE 107            GERMANY: KEY MACROINDICATORS      177

TABLE 108            GERMANY: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            177

TABLE 109            GERMANY: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            178

TABLE 110            GERMANY: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            178

TABLE 111            GERMANY: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            179

TABLE 112            GERMANY: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)            179

TABLE 113            GERMANY: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            180

TABLE 114            UK: KEY MACROINDICATORS     181

TABLE 115            UK: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            181

TABLE 116            UK: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            181

TABLE 117            UK: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            182

TABLE 118            UK: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            182

TABLE 119            UK: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE,

2023–2030 (USD MILLION)            183

TABLE 120            UK: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            183

TABLE 121            FRANCE: KEY MACROINDICATORS          184

TABLE 122            FRANCE: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            184

TABLE 123            FRANCE: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            185

TABLE 124            FRANCE: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            185

TABLE 125            FRANCE: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            186

TABLE 126            FRANCE: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)            186

TABLE 127            FRANCE: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            187

TABLE 128            ITALY: KEY MACROINDICATORS               187

TABLE 129            ITALY: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            188

TABLE 130            ITALY: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            188

TABLE 131            ITALY: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            189

TABLE 132            ITALY: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            189

TABLE 133            ITALY: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 190

TABLE 134            ITALY: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            190

TABLE 135            SPAIN: KEY MACROINDICATORS               191

TABLE 136            SPAIN: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            191

TABLE 137            SPAIN: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            191

TABLE 138            SPAIN: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            192

TABLE 139            SPAIN: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            192

TABLE 140            SPAIN: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 193

TABLE 141            SPAIN: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            193

TABLE 142            REST OF EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            194

TABLE 143            REST OF EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            194

TABLE 144            REST OF EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION)            195

TABLE 145            REST OF EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 195

TABLE 146            REST OF EUROPE: IMAGE-GUIDED NAVIGATION MARKET,

BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 196

TABLE 147            REST OF EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            196

TABLE 148            ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            199

TABLE 149            ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            199

TABLE 150            ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (UNITS SOLD)               200

TABLE 151            ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            200

TABLE 152            ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            201

TABLE 153            ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION)                 201

TABLE 154            ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)            202

TABLE 155            ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            202

TABLE 156            CHINA: KEY MACROINDICATORS             203

TABLE 157            CHINA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            203

TABLE 158            CHINA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            204

TABLE 159            CHINA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            204

TABLE 160            CHINA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            205

TABLE 161            CHINA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 205

TABLE 162            CHINA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            206

TABLE 163            JAPAN: KEY MACROINDICATORS              206

TABLE 164            JAPAN: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            207

TABLE 165            JAPAN: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            207

TABLE 166            JAPAN: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            208

TABLE 167            JAPAN: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            208

TABLE 168            JAPAN: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 209

TABLE 169            JAPAN: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            209

TABLE 170            INDIA: KEY MACROINDICATORS               210

TABLE 171            INDIA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            210

TABLE 172            INDIA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            211

TABLE 173            INDIA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            211

TABLE 174            INDIA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            212

TABLE 175            INDIA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 212

TABLE 176            INDIA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            213

TABLE 177            SOUTH KOREA: KEY MACROINDICATORS                 213

TABLE 178            SOUTH KOREA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            214

TABLE 179            SOUTH KOREA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            214

TABLE 180            SOUTH KOREA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            215

TABLE 181            SOUTH KOREA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION)                 215

TABLE 182            SOUTH KOREA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)            216

TABLE 183            SOUTH KOREA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            216

TABLE 184            AUSTRALIA: KEY MACROINDICATORS   217

TABLE 185            AUSTRALIA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            217

TABLE 186            AUSTRALIA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            218

TABLE 187            AUSTRALIA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            218

TABLE 188            AUSTRALIA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            219

TABLE 189            AUSTRALIA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)            219

TABLE 190            AUSTRALIA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            220

TABLE 191            REST OF ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            220

TABLE 192            REST OF ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)            221

TABLE 193            REST OF ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION)            221

TABLE 194            REST OF ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET,

BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION)     222

TABLE 195            REST OF ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET,

BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 222

TABLE 196            REST OF ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET,

BY END USER, 2023–2030 (USD MILLION)               223

TABLE 197            LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            224

TABLE 198            LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            224

TABLE 199            LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (UNITS SOLD)               224

TABLE 200            LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            225

TABLE 201            LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            225

TABLE 202            LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION)                 226

TABLE 203            LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET,

BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 226

TABLE 204            LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            227

TABLE 205            BRAZIL: KEY MACROINDICATORS            227

TABLE 206          BRAZIL: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            228

TABLE 207          BRAZIL: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            228

TABLE 208          BRAZIL: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            229

TABLE 209          BRAZIL: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            229

TABLE 210          BRAZIL: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 230

TABLE 211          BRAZIL: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            230

TABLE 212            MEXICO: KEY MACROINDICATORS          231

TABLE 213            MEXICO: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            231

TABLE 214            MEXICO: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            232

TABLE 215            MEXICO: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            232

TABLE 216            MEXICO: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2023–2030 (USD MILLION)            233

TABLE 217            MEXICO: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)            233

TABLE 218            MEXICO: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            234

TABLE 219            ARGENTINA: KEY MACROINDICATORS 234

TABLE 220            ARGENTINA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            235

TABLE 221            ARGENTINA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            235

TABLE 222            ARGENTINA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            236

TABLE 223            ARGENTINA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION)                 236

TABLE 224            ARGENTINA: IMAGE-GUIDED NAVIGATION MARKET,

BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 237

TABLE 225            ARGENTINA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            237

TABLE 226            REST OF LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               238

TABLE 227            REST OF LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET,

BY CARE SETTING, 2023–2030 (USD MILLION)     238

TABLE 228            REST OF LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET,

BY THERAPY AREA, 2023–2030 (USD MILLION)    239

TABLE 229            REST OF LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET,

BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION)     239

TABLE 230            REST OF LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET,

BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 240

TABLE 231            REST OF LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET,

BY END USER, 2023–2030 (USD MILLION)               240

TABLE 232            MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY REGION,

2023–2030 (USD MILLION)            241

TABLE 233            MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)                 241

TABLE 234            MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (UNITS SOLD)                 242

TABLE 235            MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)            242

TABLE 236            MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION)            243

TABLE 237            MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET,

BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION)     243

TABLE 238            MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET,

BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 244

TABLE 239            MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET,

BY END USER, 2023–2030 (USD MILLION)               244

TABLE 240            GCC COUNTRIES: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            245

TABLE 241            GCC COUNTRIES: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2023–2030 (USD MILLION)            245

TABLE 242            GCC COUNTRIES: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2023–2030 (USD MILLION)            246

TABLE 243            GCC COUNTRIES: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 246

TABLE 244            GCC COUNTRIES: IMAGE-GUIDED NAVIGATION MARKET,

BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 247

TABLE 245            GCC COUNTRIES: IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2023–2030 (USD MILLION)            247

TABLE 246            REST OF MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               248

TABLE 247            REST OF MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET,

BY CARE SETTING, 2023–2030 (USD MILLION)     248

TABLE 248            REST OF MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET,

BY THERAPY AREA, 2023–2030 (USD MILLION)    249

TABLE 249            REST OF MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET,

BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION)     249

TABLE 250            REST OF MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET,

BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION)                 250

TABLE 251            REST OF MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET,

BY END USER, 2023–2030 (USD MILLION)               250

TABLE 252            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN

IMAGE-GUIDED NAVIGATION MARKET 251

TABLE 253            IMAGE-GUIDED NAVIGATION MARKET: DEGREE OF COMPETITION         255

TABLE 254            IMAGE-GUIDED NAVIGATION MARKET: REGION FOOTPRINT     260

TABLE 255            IMAGE-GUIDED NAVIGATION MARKET: PRODUCT FOOTPRINT 261

TABLE 256            IMAGE-GUIDED NAVIGATION MARKET: CARE SETTING FOOTPRINT   261

TABLE 257            IMAGE-GUIDED NAVIGATION MARKET: THERAPY AREA FOOTPRINT      262

TABLE 258            IMAGE-GUIDED NAVIGATION MARKET: TYPE OF NAVIGATION FOOTPRINT    263

TABLE 259            IMAGE-GUIDED NAVIGATION MARKET: REFERENCE MODALITY TYPE FOOTPRINT          264

TABLE 260            IMAGE-GUIDED NAVIGATION MARKET: DETAILED LIST OF KEY

STARTUPS/SME PLAYERS             267

TABLE 261            IMAGE-GUIDED NAVIGATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS                 268

TABLE 262            IMAGE-GUIDED NAVIGATION MARKET: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS, JANUARY 2022–MARCH 2025         271

TABLE 263            IMAGE-GUIDED NAVIGATION MARKET: DEALS, JANUARY 2022–MARCH 2025         272

TABLE 264            IMAGE-GUIDED NAVIGATION MARKET: EXPANSIONS, JANUARY 2022–MARCH 2025            274

TABLE 265            MEDTRONIC: COMPANY OVERVIEW       275

TABLE 266            MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED    276

TABLE 267            MEDTRONIC: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025             277

TABLE 268            MEDTRONIC: DEALS, JANUARY 2022–MARCH 2025        278

TABLE 269            MEDTRONIC: EXPANSIONS: JANUARY 2022–MARCH 2025       278

TABLE 270            BRAINLAB AG: COMPANY OVERVIEW     280

TABLE 271            BRAINLAB AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED    280

TABLE 272            BRAINLAB AG: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025         281

TABLE 273            BRAINLAB AG: DEALS, JANUARY 2022–MARCH 2025        282

TABLE 274            STRYKER: COMPANY OVERVIEW               284

TABLE 275            STRYKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED             285

TABLE 276            STRYKER: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025             286

TABLE 277            B. BRAUN SE: COMPANY OVERVIEW       288

TABLE 278            B. BRAUN SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED    289

TABLE 279            B. BRAUN SE.: DEALS, JANUARY 2022–MARCH 2025        290

TABLE 280            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          292

TABLE 281            KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    293

TABLE 282            KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025                294

TABLE 283            GE HEALTHCARE: COMPANY OVERVIEW                 296

TABLE 284            GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED    297

TABLE 285            GE HEALTHCARE: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025         298

TABLE 286            GE HEALTHCARE: DEALS, JANUARY 2022–MARCH 2025       298

TABLE 287            OLYMPUS CORPORATION: COMPANY OVERVIEW          299

TABLE 288            OLYMPUS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED    300

TABLE 289            OLYMPUS CORPORATION: DEALS, JANUARY 2022–MARCH 2025             301

TABLE 290            SMITH+NEPHEW: COMPANY OVERVIEW                 302

TABLE 291            SMITH+NEPHEW: PRODUCTS/SERVICES/SOLUTIONS OFFERED    303

TABLE 292            SMITH+NEPHEW: DEALS, JANUARY 2022–MARCH 2025       303

TABLE 293            JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW   304

TABLE 294            JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS/SERVICES/

SOLUTIONS OFFERED   305

TABLE 295            JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022–MARCH 2025         306

TABLE 296            GLOBUS MEDICAL (NUVASIVE): COMPANY OVERVIEW          307

TABLE 297            GLOBUS MEDICAL (NUVASIVE): PRODUCTS/SERVICES/SOLUTIONS OFFERED    308

TABLE 298            GLOBUS MEDICAL (NUVASIVE): DEALS, JANUARY 2022–MARCH 2025         309

TABLE 299            STEREOTAXIS, INC.: COMPANY OVERVIEW                 310

TABLE 300            STEREOTAXIS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    311

TABLE 301            STEREOTAXIS, INC.: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025         311

TABLE 302            STEREOTAXIS, INC.: DEALS, JANUARY 2022–MARCH 2025       312

TABLE 303            ORTHOFIX MEDICAL INC.: COMPANY OVERVIEW          313

TABLE 304            ORTHOFIX MEDICAL INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    314

TABLE 305            ORTHOFIX MEDICAL INC.: DEALS, JANUARY 2022–MARCH 2025             315

TABLE 306            INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW   316

TABLE 307            INTEGRA LIFESCIENCES CORPORATION: PRODUCTS/SERVICES/

SOLUTIONS OFFERED   317

TABLE 308          INTEGRA LIFESCIENCES CORPORATION: DEALS, JANUARY 2022–MARCH 2025         318

TABLE 309            ZIMMER BIOMET: COMPANY OVERVIEW                 319

TABLE 310            ZIMMER BIOMET: PRODUCTS/SERVICES/SOLUTIONS OFFERED    320

TABLE 311            ZIMMER BIOMET: DEALS, JANUARY 2022–MARCH 2025       321

TABLE 312            INTUITIVE SURGICAL: COMPANY OVERVIEW                 322

TABLE 313            INTUITIVE SURGICAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED    323

TABLE 314          INTUITIVE SURGICAL: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025         323

TABLE 315            KARL STORZ: COMPANY OVERVIEW       324

TABLE 316            FIAGON GMBH: COMPANY OVERVIEW  325

TABLE 317            ZETA SURGICAL INC.: COMPANY OVERVIEW                 326

TABLE 318            BRAIN NAVI BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW   327

TABLE 319            IMAGE NAVIGATION, LTD.: COMPANY OVERVIEW          328

TABLE 320            HAPPY RELIABLE SURGERIES PVT. LTD.: COMPANY OVERVIEW   329

TABLE 321            RXOOM HEALTHCARE PVT. LTD.: COMPANY OVERVIEW          330

TABLE 322            CLARONAV: COMPANY OVERVIEW          331

TABLE 323          SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.: COMPANY OVERVIEW       331

TABLE 324            ZIEHM IMAGING GMBH: COMPANY OVERVIEW                 332

LIST OF FIGURES

FIGURE 1              IMAGE-GUIDED NAVIGATION MARKET: SEGMENTS CONSIDERED &

GEOGRAPHICAL SCOPE                31

FIGURE 2              IMAGE-GUIDED NAVIGATION MARKET: YEARS CONSIDERED    33

FIGURE 3              IMAGE-GUIDED NAVIGATION MARKET: RESEARCH DESIGN         35

FIGURE 4              IMAGE-GUIDED NAVIGATION MARKET: KEY DATA FROM SECONDARY SOURCES        37

FIGURE 5              IMAGE-GUIDED NAVIGATION MARKET: KEY PRIMARY SOURCES         38

FIGURE 6              IMAGE-GUIDED NAVIGATION MARKET: KEY DATA FROM PRIMARY SOURCES               39

FIGURE 7              IMAGE-GUIDED NAVIGATION MARKET: KEY INSIGHTS FROM PRIMARIES       40

FIGURE 8              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND OTHER PARTICIPANTS            40

FIGURE 9              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION                41

FIGURE 10            BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):

BY END USER, DESIGNATION, AND REGION        41

FIGURE 11            IMAGE-GUIDED NAVIGATION MARKET: SUPPLY-SIDE MARKET

SIZE ESTIMATION (REVENUE SHARE ANALYSIS)                42

FIGURE 12            IMAGE-GUIDED NAVIGATION MARKET: REVENUE SHARE

ANALYSIS ILLUSTRATION FOR MEDTRONIC (2024)          43

FIGURE 13            IMAGE-GUIDED NAVIGATION MARKET: TOP-DOWN APPROACH          43

FIGURE 14            IMAGE-GUIDED NAVIGATION MARKET: SUPPLY-SIDE ANALYSIS (2024)   46

FIGURE 15            CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN IMAGE-GUIDED NAVIGATION MARKET 47

FIGURE 16            IMAGE-GUIDED NAVIGATION MARKET: CAGR PROJECTIONS   47

FIGURE 17            IMAGE-GUIDED NAVIGATION MARKET: DATA TRIANGULATION             48

FIGURE 18            IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT,

2025 VS. 2030 (USD MILLION)      51

FIGURE 19            IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING,

2025 VS. 2030 (USD MILLION)      52

FIGURE 20            IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA,

2025 VS. 2030 (USD MILLION)      52

FIGURE 21            IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION,

2025 VS. 2030 (USD MILLION)      53

FIGURE 22            IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE,

2025 VS. 2030 (USD MILLION)      54

FIGURE 23            IMAGE-GUIDED NAVIGATION MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      54

FIGURE 24            IMAGE-GUIDED NAVIGATION MARKET: REGIONAL SNAPSHOT  55

FIGURE 25            INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING ADOPTION OF MINIMALLY INVASIVE SURGICAL PROCEDURES TO DRIVE MARKET      56

FIGURE 26            US AND WORKSTATIONS & SOFTWARE SEGMENT COMMANDED

LARGEST NORTH AMERICAN MARKET SHARE IN 2024    57

FIGURE 27            ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING STUDY PERIOD               57

FIGURE 28            CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030          58

FIGURE 29            EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES

DURING FORECAST PERIOD       59

FIGURE 30            IMAGE-GUIDED NAVIGATION MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES     61

FIGURE 31            NUMBER OF MINIMALLY INVASIVE SURGICAL PROCEDURES IN US (2018–2023)                 62

FIGURE 32            IMAGE-GUIDED NAVIGATION MARKET: PORTER’S FIVE FORCES ANALYSIS           72

FIGURE 33            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT               74

FIGURE 34            KEY BUYING CRITERIA FOR IMAGE-GUIDED NAVIGATION SYSTEMS, BY END USER    75

FIGURE 35            IMAGE-GUIDED NAVIGATION MARKET: PATENT PUBLICATION TRENDS, JURISDICTION, AND TOP APPLICANT ANALYSIS (JANUARY 2014–MARCH 2025)       82

FIGURE 36            TOP APPLICANT COUNTRIES/REGIONS FOR IMAGE-GUIDED

NAVIGATION PATENTS (JANUARY 2014–MARCH 2025)    83

FIGURE 37            IMAGE-GUIDED NAVIGATION MARKET: VALUE CHAIN ANALYSIS              89

FIGURE 38            IMAGE-GUIDED NAVIGATION MARKET: SUPPLY CHAIN ANALYSIS              90

FIGURE 39            IMAGE-GUIDED NAVIGATION MARKET: ECOSYSTEM ANALYSIS  91

FIGURE 40            ADJACENT MARKETS FOR IMAGE-GUIDED NAVIGATION MARKET  93

FIGURE 41            IMAGE-GUIDED NAVIGATION MARKET: TRENDS/DISRUPTIONS

IMPACTING CUSTOMER’S BUSINESS      94

FIGURE 42            IMAGE-GUIDED NAVIGATION MARKET: FUNDING AND NUMBER OF

DEALS, 2020–2024              94

FIGURE 43            IMAGE-GUIDED NAVIGATION MARKET: GEOGRAPHIC SNAPSHOT            159

FIGURE 44            NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET SNAPSHOT          161

FIGURE 45            ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET SNAPSHOT       198

FIGURE 46            REVENUE ANALYSIS OF KEY PLAYERS IN IMAGE-GUIDED

NAVIGATION MARKET (2020–2024)           254

FIGURE 47            MARKET SHARE ANALYSIS FOR KEY PLAYERS IN IMAGE-GUIDED

NAVIGATION MARKET (2024)     255

FIGURE 48            IMAGE-GUIDED NAVIGATION MARKET: COMPANY EVALUATION MATRIX:

KEY PLAYERS (2024)        258

FIGURE 49            IMAGE-GUIDED NAVIGATION MARKET: COMPANY FOOTPRINT 259

FIGURE 50            IMAGE-GUIDED NAVIGATION MARKET: COMPANY EVALUATION MATRIX: STARTUPS/SMES (2024)                 266

FIGURE 51            EV/EBITDA OF KEY VENDORS   269

FIGURE 52            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                269

FIGURE 53            IMAGE-GUIDED NAVIGATION MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     270

FIGURE 54            R&D ASSESSMENT OF KEY PLAYERS IN IMAGE-GUIDED NAVIGATION MARKET (2022–2024)         271

FIGURE 55            MEDTRONIC: COMPANY SNAPSHOT      276

FIGURE 56            STRYKER: COMPANY SNAPSHOT              285

FIGURE 57            B. BRAUN SE: COMPANY SNAPSHOT       289

FIGURE 58            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT          293

FIGURE 59            GE HEALTHCARE: COMPANY SNAPSHOT                 297

FIGURE 60            OLYMPUS CORPORATION: COMPANY SNAPSHOT          300

FIGURE 61            SMITH+NEPHEW: COMPANY SNAPSHOT                 302

FIGURE 62            JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT   305

FIGURE 63            GLOBUS MEDICAL (NUVASIVE): COMPANY SNAPSHOT          308

FIGURE 64            STEREOTAXIS, INC.: COMPANY SNAPSHOT                 310

FIGURE 65            ORTHOFIX MEDICAL INC.: COMPANY SNAPSHOT          314

FIGURE 66            INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT   317

FIGURE 67            ZIMMER BIOMET: COMPANY SNAPSHOT                 320

FIGURE 68            INTUITIVE SURGICAL: COMPANY SNAPSHOT                 322